Ignite Creation Date:
2024-05-06 @ 1:37 AM
Last Modification Date:
2024-10-26 @ 11:07 AM
Study NCT ID:
NCT01854372
Status:
WITHDRAWN
Last Update Posted:
2013-12-10
First Post:
2013-05-10
Brief Title:
Rituximab-HyperCVAD R-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine- R-MC in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma With MYC-Rearrangement
Sponsor:
Organization:
The University of Texas Health Science Center at San Antonio